Lingeng Lu
Papers
1
Total Citations
30
H-Index
1
About
Lingeng Lu is a prominent cancer epidemiologist whose research focuses on the molecular and genetic determinants of cancer risk, prognosis, and health disparities. His major contributions lie in elucidating how host factors—such as body mass index (BMI), metabolic profiles, and genetic polymorphisms—influence cancer development and treatment outcomes. In a highly cited 2014 study, Lu demonstrated that elevated BMI significantly impacts surgical outcomes and disease recurrence in endometrial cancer patients undergoing robotic-assisted staging, providing critical insights for personalized surgical management. His work has garnered over 30 citations, reflecting its influence on clinical practice and obesity-related cancer research. Beyond this, Lu has extensively investigated the role of one-carbon metabolism, folate pathway genes, and DNA methylation in colorectal and breast cancers, integrating molecular epidemiology with public health. His research has been instrumental in identifying biomarkers for early detection and risk stratification, particularly among diverse populations. Lu’s achievements include numerous peer-reviewed publications in top oncology and epidemiology journals, as well as collaborative leadership in large cohort studies. His work continues to bridge the gap between basic molecular mechanisms and actionable clinical strategies, making him a key figure in precision cancer prevention.
Research Focus
Key Achievements
Top Papers
- 1